Facebook Linkedin RSS Twitter Youtube
Home 2024

Ebola vaccine

Vaccine Developers Leverage mRNA and Other Powerful Technologies
Infectious Diseases

Vaccine Developers Leverage mRNA and Other Powerful Technologies

Ebola Vaccine Good News: Clinical Trial Shows Strong Immune Response
Drug Discovery

Ebola Vaccine Good News: Clinical Trial Shows Strong Immune Response

Why Biopharma Should Consider Plant-Based Manufacturing
Bioprocessing

Why Biopharma Should Consider Plant-Based Manufacturing

Gene Therapy Advanced by Structural Study of Potential Viral Vectors
Drug Discovery

Gene Therapy Advanced by Structural Study of Potential Viral Vectors

Integral Molecular Sizes Up Ebola
Insights

Integral Molecular Sizes Up Ebola

Bavarian Nordic Wins Up-to-$33M Janssen Subcontract for Ebola Vaccine Regimen
Bioprocessing

Bavarian Nordic Wins Up-to-$33M Janssen Subcontract for Ebola Vaccine Regimen

Merck-NewLink Genetics Ebola Vaccine Shows 100% Efficacy in Phase III Trial
Drug Discovery

Merck-NewLink Genetics Ebola Vaccine Shows 100% Efficacy in Phase III Trial

NewLink Wins $20M from Merck & Co. for Ebola Vaccine Trial Launch
Drug Discovery

NewLink Wins $20M from Merck & Co. for Ebola Vaccine Trial Launch

GSK Ebola Vaccine Shipped to Liberia for Phase III Trial
Infectious Diseases

GSK Ebola Vaccine Shipped to Liberia for Phase III Trial

Consortium Wins $115M toward Work with J&J on Ebola Vaccine
Drug Discovery

Consortium Wins $115M toward Work with J&J on Ebola Vaccine

12Page 1 of 2
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.